Xilio Therapeutics had a revenue of 8.08M in the quarter ending Jun 30, 2025, with 175.90%. This bring the company's revenue in the last twelve months to 15.00M, Decreased 61.75%. In the fiscal year ending Dec 31, 2024, Xilio Therapeutics had annual revenue of 6.34M with Infinity% growth.